ClinicalTrials.Veeva

Menu

Gustatory Modulators Among a Sample of Depressed Egyptian Adults Under Anti-depressants Therapy

Cairo University (CU) logo

Cairo University (CU)

Status

Completed

Conditions

Taste Disorders

Study type

Observational

Funder types

Other

Identifiers

NCT04923425
18936 CairoU

Details and patient eligibility

About

Identify possible modulators for developing gustatory dysfunction among a sample of depressed Egyptian adults (age from 20 to 50 years old) under anti-depressants therapy ( for at least 3 months) using a questionnaire ( appendix) with a binary measuring unit (yes/no).

Full description

PECO

  • P Population: depressed Egyptian adults under anti-depressants therapy
  • E1 Exposure 1: commonly prescribed tricyclic antidepressants (Imipramine, Amitriptyline, Clomipramine HCL)
  • E2 Exposure 2: commonly prescribed Selective Serotonin Re-uptake inhibitors antidepressants ( Fluoxetine, Fluvoxamine, Sertraline, Citalopram, Paroxetine)
  • C control (non exposure) : non-pharmacological treatment ( psychotherapy)
  • O Outcome: Identify possible gustatory dysfunction modulators among these patients using a questionnaire ( appendix) with a binary measuring unit (yes/no).

Enrollment

30 patients

Sex

All

Ages

20 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • • Depressed Egyptian adults under antidepressants therapy for at least 3 months/non-pharmacological treatment( psychotherapy)

    • Age from 20 to 50 years old

Exclusion criteria

  • Antipsychotics

    • Hypnotics
    • Anticonvulsants
    • Ages other than the mentioned • Olfactory dysfunction
    • Chemosensory dysfunction

Trial design

30 participants in 3 patient groups

Exposure 1
Description:
commonly prescribed tricyclic antidepressants (Imipramine, Amitriptyline, Clomipramine HCL) administered for at least 3 months
Exposure 2
Description:
commonly prescribed Selective Serotonin Re-uptake inhibitors antidepressants ( Fluoxetine, Fluvoxamine, Sertraline, Citalopram, Paroxetine) administered for at least 3 months
Non exposure
Description:
Non-pharmacological treatment (psychotherapy)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems